“…The idea that SARS-CoV-2 infection could be associated with long-term health outcomes first appeared in the literature in mid-2020 [11], along with previous evidence of longhaul symptoms following the Ebola [12] virus outbreak and infections from previous coronaviruses [13,14]. COVID-19 survivors have been shown to experience a constellation of symptoms such as fatigue, dyspnea or breathlessness [8,15], palpitations [16,17], brain fog, lack of concentration [18,19], sleep disturbances (i.e., insomnia) [20], headache [17,[21][22][23][24][25], orthostatic intolerance [25], anxiety and post-traumatic stress disorder [20,23,[26][27][28], chest pain, joint pain [8], sore throat [17], and hair loss [15] persisting >4 weeks after recovery. These clinical sequelae share similarities with post-acute symptoms reported after severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) epidemics, caused by previous coronaviruses [14].…”